Clinical trial · Interventional
A Pharmacokinetic Study of Nutri-PEITC Jelly in Head and Neck Cancer Survivors
A Pharmacokinetic Study of PEITC in Nutri-Jelly in Healthy Head and Neck Cancer Survivors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This research aims to evaluate the absorption and elimination profile of a bioactive compound PEITC in the matrix of Nutri-jelly - a novel edible nutritious gel. Thus, the investigators conducted a pharmacokinetic study in 12 head and neck cancer survivors. After consumed a serving of Nutri-jelly containing 20 mg PEITC, plasma levels of PEITC at 0, 1, 2, 3, 4, 6, 8, 12 and 24 hours were specifically measured by ammonia derivatization and analyzed by liquid chromatography-mass spectrometry (LC-MS/MS). Non-compartmental pharmacokinetic analysis was performed.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Nutri-PEITC jelly | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Nutri-PEITC jelly
- description
- a single serving of 200 g Nutri-PEITC jelly
- interventionNames
- Dietary Supplement: Nutri-PEITC jelly
Primary outcomes (2)
- measure
- Maximum plasma concentration (Cmax) of PEITC
- timeFrame
- Day 0 - Day 1
- description
- Plasma concentration of PEITC during 24 hours after intake of Nutri-jelly will be measured and the highest concentration will be identified.
- measure
- Time to reach maximum concentration (Tmax)
- timeFrame
- Day 0 - Day 1
- description
- The duration to reach maximum plasma concentration of PEITC will be calculated.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * age 20 or above * Diagnosed with Head and neck cancer * Completed radiation or chemotherapy since at least 4 weeks ago * normal physical exam * Eastern Cooperative Oncology Group (ECOG) performance status 0 - 2 * Life expectancy \> 3 months * Normal kidney function evidenced by serum creatinine, blood urea nitrogen (BUN), no kidney stone, no history of renal dialysis * Normal liver function evidenced by serum bilirubin, aspartate transaminase (AST), alanine amino transferase (ALT) * not pregnant or breastfeeding * no psychiatric symptoms * normal vital sign and normal blood chemistry including complete blood count CBC) * provide voluntary inform consent Exclusion Criteria: * unable to communicate * reject to take Nutri-jelly * unable to refrain from vegetable intake for 3 days prior to the test * take paracetamol during 2 days prior to the test * body weight less than 35 kg or higher than 65 kg * oral infection such as Candidiasis interfering with normal oral intake
References
Publications (0)
Data not yet available